The customer who represents 25% of your revenue is not your best customer. They are your most dangerous liability.
Every pricing decision you make is constrained by the question of whether they will accept it. Every contract renewal is a negotiation where they hold the leverage. Every operational failure is amplified because the consequences of losing them are existential.
You have built a business that is structurally dependent on a single counterparty — and that dependency is costing you margin, strategic freedom and enterprise value every month.
The Cost That Is Never Measured
Customer concentration is a form of external bleed that is rarely measured as a cost. It shows up instead as a pattern of decisions: the discount approved to retain the account, the additional scope delivered to keep them happy, the payment terms extended because you cannot afford to push back.
Each of these decisions is rational in isolation. In aggregate, they represent a systematic transfer of margin from your company to your largest customer.
The four channels through which concentration destroys margin:
| Channel | Typical Cost |
|---|---|
| Discount given at renewal to avoid a competitive tender | 8–15% of contract value |
| Additional scope delivered without a change order | 5–10% of project margin |
| Extended payment terms accepted to avoid a dispute | 30–60 days of working capital tied up |
| Pricing increase not pursued because the account feels too important to risk | 3–5% of annual revenue foregone |
Price all four categories on a customer who represents 25% of your revenue, and the total cost of the concentration is not 25% of revenue. It is 25% of revenue multiplied by a margin transfer rate of 15–30%. That is 4–8% of total company revenue given away to manage a risk that has never been formally priced.
The Manufacturing Risk: When the Factory Runs on One Customer's Economics
In manufacturing, customer concentration creates operational risk as well as commercial risk. When a single customer represents a large share of production volume, the production schedule is built around their requirements.
- When they change their order, the schedule changes
- When they delay payment, the cash flow changes
- When they reduce volume, the fixed cost absorption changes
The factory is not running on its own economics. It is running on the economics of one customer — and the factory bears all the downside risk of that dependency while the customer retains all the upside optionality.
The operational consequence is a production system that cannot be optimised for efficiency because it must remain flexible enough to accommodate one customer's unpredictability. The commercial consequence is a pricing structure that cannot be defended because the customer knows you cannot afford to lose the volume.
The Technology Risk: When the Product Roadmap Belongs to One Client
In technology companies, customer concentration creates product risk. When a single enterprise customer represents a large share of ARR, the product roadmap is shaped by their feature requests.
The product becomes a custom solution for one customer rather than a scalable platform for many. The engineering team builds what the customer asks for rather than what the market needs. The product drifts away from its original positioning — and the company becomes harder to sell or raise capital for.
The compounding effect on valuation is severe:
1. The product is no longer differentiated in the market — it is optimised for one buyer
2. The customer base cannot be diversified quickly because the product no longer fits the broader market
3. Investors apply a concentration discount and a product-market-fit discount simultaneously
4. The exit multiple contracts at precisely the moment the founder expected it to expand
This is why customer concentration is not just a commercial problem. It is a capital readiness problem — one that destroys enterprise value long before the founder realises it.
Pricing the Concentration Correctly: The Number Most CEOs Have Never Calculated
The standard advice for customer concentration is to diversify. This is correct but incomplete. Diversification takes time, and the cost of concentration is being paid now.
The more immediate intervention is to price the concentration correctly.
A worked example — $10M revenue business, 25% customer concentration:
- Customer represents $2.5M of annual revenue
- Discount given to retain them: 15% = $375,000/year in direct margin transfer
- Over a five-year period, at a 6x EBITDA multiple: $2.25M in enterprise value destroyed
- This is before accounting for extended payment terms, additional scope, or foregone price increases
> The CEO who has never calculated this number is making pricing and relationship decisions without knowing their true cost.
The Valuation Impact: What Investors See That Founders Miss
Investors apply a concentration discount to any business where a single customer represents more than 15–20% of revenue. The discount is typically 1–2x EBITDA.
For a business with $2M in EBITDA:
- A 1x EBITDA concentration discount reduces enterprise value by $2M
- A 2x EBITDA concentration discount reduces enterprise value by $4M
- That is $2–4M in valuation that can be recovered by reducing concentration before a capital process begins
The CEO who addresses customer concentration before a capital raise or exit will receive a materially higher valuation than the CEO who does not. Not because the business is fundamentally different — but because the risk profile is.
How EVOSYST Addresses Customer Concentration
The Business Model and Expansion Protection engagement addresses customer concentration through a structured diversification programme. The target is to reduce the largest customer's share of revenue below 15% within the engagement term, while maintaining or improving total revenue.
The intervention is not simply "go find more customers." It is a structured commercial programme that:
- Prices the current concentration cost accurately and reports it to the CEO monthly
- Identifies the customer segments most likely to generate diversified revenue quickly
- Builds the commercial infrastructure — pricing authority, contract terms, sales process — to win and retain new accounts without replicating the concentration dynamic
- Manages the existing concentrated relationship commercially rather than relationally, recovering margin from the discounts and scope that have been given away
The output is a business that is not only less concentrated — it is more commercially disciplined, more defensible to investors, and more valuable at exit.
*To find out what your largest customer is actually costing you, start with the Executive Leak Assessment. Two weeks. A priced report of the concentration risk and the margin it is consuming.*
About the Author
M.K. Hasan
Founder, EVOSYST · Global CHRO & Strategic Advisor to CEOs
M.K. Hasan helps CEOs and Boards find the revenue their business is losing and get it back. He works across Strategy, People and Operations through focused diagnostic and recovery sprints.
Request an Executive Leak Assessment